Dr. Vincent Giampapa is a renowned cellular aging expert, surgeon, and clinical researcher. CellHealth Institute represents Dr. Giampapa's most advanced cellular health venture, which is informed by his decades of research, clinical practice and consultation for other biotechnology companies. He has practiced clinical age-management medicine for over 20 years, and is the founding member of the American Academy of Anti-Aging Medicine. He was also the first board-certified anti-aging physician in the world.
Dr. Giampapa's research focuses on stem cell technologies and their clinical applications to improve the cellular aging process in order to enhance health span and quality of life. As a result of his research, Dr. Giampapa has been awarded medical and intellectual property patents with the United States Patent and Trademark Office for developments involving unique cell culture delivery techniques, new drug delivery systems, stem cell reprogramming, DNA repair, and telomerase maintenance. His familiarity in advanced medical technology allowed him to lend his expertise to NASA on the design of a space shuttle robotic arm.
Dr. Giampapa is the author of six books on age management, including the first and only medical textbook on anti-aging medicine titled The Principles and Practice of Anti-Aging Medicine for the Aesthetic Surgeon and Physician. He has also published work in numerous academic journals, including: Journal of Anti-Aging Medicine, Journal of Plastic Reconstructive Surgery, and Journal of Reconstructive Microsurgery.
Dr. Giampapa is also a renowned plastic and reconstructive surgeon operating out of Hackensack University Medical Center. He uses his expertise philanthropically as well, having performed reconstructive surgery on children with disfigurements. He earned his M.D. from Mt. Sinai Medical School and is a Fellow of the American College of Surgeons. Additionally, he teaches at the University of Medicine & Dentistry of New Jersey as an assistant clinical professor.
In April 2013 Dr. Giampapa presented his adult stem cell restoration study at The Second International Vatican Stem Cell Conference on Regenerative Medicine in Rome, Italy.Dr. Giampapa presented an update to the stem cell reprogramming study at the Swedish American Life Sciences Summit in Stockholm, Sweden in August. Also in MAY 2013 Dr. Giampapa accepted a Bronze Edison Innovation Award on behalf of CHI in the category of Personal Wellness at the ceremony held in Chicago, IL. Dr. Giampapa’s research continues as Rutgers University with a team of stem cell biologists focusing on the future use of adult stem cell therapy to improve the quality of time and health of the world’s aging population.